# The Global Morbidity Gap Widened from 1990 to 2023 > GBD 2023 modeled estimates indicate that the difference between life expectancy and healthy life expectancy grew worldwide, sharpening the case for policy that protects healthspan as well as lifespan. _Source: The Lancet Public Health and PubMed · 2026-07-27 · 6 min read · Verified against primary sources_ Canonical: https://iyu.app/e/global-morbidity-gap-1990-2023 ## The 60-second version GBD 2023 modeling estimates that the global difference between life expectancy and HALE widened from 1990 to 2023 across nearly every location. **Key points** - The gap rose from 8.8 years (95% UI 6.7–11.2) to 10.7 (8.2–13.7), an increase of 1.9 years (1.3–2.6) or 21.9% (16.0–27.9). - Point estimates widened in 203 of 204 locations, while the poor-health share rose from 13.6% to 14.5%. - Widening occurred across adult life, not only near death; five nonfatal condition groups jointly represented 57.4% of unhealthy years. - These are population-level modeled estimates with uncertainty, not direct longitudinal observations or personal forecasts. **Verdict.** Longer life is a gain; policy must now give equal weight to healthspan through prevention, chronic-care management, rehabilitation, and support for function. ## Full explainer > **i** **Definition:** the morbidity gap is life expectancy minus healthy life expectancy (HALE). It estimates years not lived in full health at the population level; it is not an individual prognosis. ### Measure — Two clocks of population health Longer survival is a major public-health achievement, but survival alone does not describe whether people can move, hear, work, care for others, or participate without disabling symptoms. The study therefore compares **life expectancy**, the expected length of life under prevailing mortality patterns, with **healthy life expectancy (HALE)**, which adjusts expected years for time lived with less than full health. Subtracting HALE from life expectancy produces the **morbidity gap**. A wider gap means that more expected years are lived with some health loss at the population level. It does not mean every person will experience that many years of illness, and it does not specify severity, sequence, or diagnosis for an individual. > **!** The analysis uses **GBD 2023 modeled estimates for 204 countries and territories**. It is not direct longitudinal observation of the same people over 33 years. Uncertainty intervals reflect uncertainty in data and modeling, and comparisons should retain them. ### Results — A global increase, with uncertainty - **8.8 years** — 1990 gap; 95% UI 6.7–11.2 - **10.7 years** — 2023 gap; 95% UI 8.2–13.7 - **+1.9 years** — change; 95% UI 1.3–2.6 - **+21.9%** — relative change; 95% UI 16.0–27.9 The estimated global gap rose from **8.8 years in 1990 (95% uncertainty interval 6.7–11.2)** to **10.7 years in 2023 (8.2–13.7)**. The increase was **1.9 years (1.3–2.6)**, or **21.9% (16.0–27.9)**. These intervals are essential: the point estimates summarize a modeled distribution rather than exact counts. - **1990 morbidity gap:** 8.8 years (95% UI 6.7–11.2) - **2023 morbidity gap:** 10.7 years (95% UI 8.2–13.7) - **Absolute increase:** 1.9 years (95% UI 1.3–2.6) - **Relative increase:** 21.9% (95% UI 16.0–27.9) - **Share in poor health:** 13.6% in 1990; 14.5% in 2023 Point estimates widened in **203 of 204 locations**. The proportion of life expectancy represented by poor health increased from **13.6% to 14.5%**. Near-universality in point estimates makes this a broad global pattern, but it does not establish one shared causal mechanism in every setting. > The added years of impaired health were distributed across the adult life course, not confined to the final stage of life. That age pattern matters. A morbidity gap spread through adulthood can affect education, paid work, caregiving, social participation, and demand for recurring care. Policy limited to end-of-life services would therefore miss much of the burden described by the model. ### Distribution — Development changes the pattern, but not simply High Socio-demographic Index, or SDI, settings had the largest **absolute** morbidity gaps. The proportional relationship between the gap and SDI was less clear. This distinction blocks an easy causal story: places can achieve long life while still accumulating substantial nonfatal disability, but the analysis does not show that socioeconomic development itself produces the widening. #### What fills the gap Five broad groups jointly accounted for **57.4% of unhealthy years**: musculoskeletal disorders, particularly low back pain; mental disorders, including depression and anxiety; sense-organ conditions, especially age-related hearing loss; falls; and other noncommunicable diseases. Their importance is easy to understate when mortality dominates health reporting, because many cause long-lasting limitation without being the immediate cause of death. - **Musculoskeletal health:** low back pain and related disability can persist across working and older ages. - **Mental health:** depression and anxiety can impair function even when they do not appear in mortality statistics. - **Sensory health:** age-related hearing loss can reduce communication, safety, and participation. - **Falls and other NCDs:** prevention, rehabilitation, and continuing management can influence independence. #### Risk factors are signals, not deterministic causes The leading attributed risks included **high fasting plasma glucose**, **high body-mass index**, and **child and maternal malnutrition**. They span metabolic and early-life pathways, reinforcing a life-course perspective. Yet GBD risk attribution is comparative modeling: it does not prove that a single intervention will remove an equivalent amount of morbidity, nor that the observed time trend was caused by those risks alone. ### Interpretation — Healthspan should stand beside lifespan The proper conclusion is not that medicine failed or that living longer is undesirable. Mortality reduction remains valuable. The result identifies a second obligation: prevent avoidable disability and help people live well with conditions that cannot be fully prevented or cured. > **>** A healthspan agenda would track HALE alongside life expectancy; strengthen prevention and primary care; expand rehabilitation, pain, mental-health, and hearing services; prevent falls; and address metabolic and nutritional risks without neglecting social access. Because the gap appears throughout adult life, action should begin before old age and continue through long-term management. Outcomes should include function, autonomy, symptom control, participation, and equitable access, rather than mortality alone. ### Transparency — Funding, disclosures, and access The work was funded by the **Gates Foundation**; the paper reports that the funder had no role in the study. One author declared a Japanese grant, while the other authors reported no conflicts of interest. The article is available open access under the **Creative Commons Attribution 4.0 (CC BY 4.0)** license. These disclosures support appraisal but do not by themselves confirm or invalidate the findings. ## Primary sources - [The Lancet Public Health: full text](https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(26)00098-8/fulltext) - [PubMed record](https://pubmed.ncbi.nlm.nih.gov/42480564/) --- _Published by iyu (https://iyu.app) — the day's AI news, checked against primary sources and rewritten in plain language. Free to quote with attribution and a link to the canonical URL._